This CME Activity has expired and is no longer available for credit.
Allergic Rhinitis: Practical Management for Improved Quality of Life—Strategies for Primary Care Clinicians
Time to Complete
March 31, 2012
July 31, 2013
1.00 / AMA PRA Category 1 Credit(s)TM
This program is sponsored by Albert Einstein College of Medicine of Yeshiva University.
This program is supported by an educational grant from Meda Pharmaceuticals, Inc.
In evaluating patients with suspected allergic rhinitis (AR), knowing the allergens and obtaining an accurate diagnosis are essential in selecting appropriate treatment that is individualized to the patient, increases the likelihood of efficacy, and improves quality of life. The case study interwoven throughout this online monograph exemplifies how the common pitfalls of AR diagnosis and treatment can be avoided in your practice.
Primary care physicians, nurse practitioners, and physician assistants who care for allergy patients
Upon completion of this educational activity, clinicians should be better able to:
Describe the prevalence, symptoms, and burden of illness of allergic rhinitis (AR).
Implement strategies to increase accurate identification of patients with AR.
Evaluate the benefits and limitations of current and emerging therapies for AR.
Provide patient education about effective management for AR
Disclosure of Conflicts of Interest
Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
CHAIR Warner W. Carr, MD, FAAAAI, FACAAI, FACP Associate Medical Director Allergy & Asthma Associates of Southern California Southern California Research Mission Viejo, California
Warner W. Carr, MD, FAAAAI, FACAAI, FACP, has received grant/research from Meda Pharmaceuticals, Inc., Alcon Laboratories, Inc., and ISTA Pharmaceuticals, Inc. He is a consultant for Meda Pharmaceuticals, Inc., Alcon Laboratories, Inc., ISTA Pharmaceuticals, Inc., and Sunovion Pharmaceuticals Inc. Dr. Carr is also on the speakers’ bureaus for Meda Pharmaceuticals, Inc., Alcon Laboratories, Inc., ISTA Pharmaceuticals, Inc., GlaxoSmithKline, Merck & Co., Inc.
FACULTY Stuart W. Stoloff, MD, FAAAAI, FAAFP Clinical Professor Department of Family and Community Medicine University of Nevada School of Medicine Reno, Nevada
Stuart W. Stoloff, MD, FAAAAI, FAAFP, is a consultant for Merck & Co., Inc., Teva Pharmaceuticals USA, Aerocrine, Sunovion Pharmaceuticals Inc., and AstraZeneca.
CME COURSE REVIEWER David L. Rosenstreich, MD Professor, Department of Medicine (Allergy & Immunology) Albert Einstein College of Medicine of Yeshiva University Bronx, New York
David L. Rosenstreich, MD, has nothing to disclose with regard to commercial support.
Accreditor Staff Disclosures
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine of Yeshiva University has nothing to disclose with regard to commercial support.
Publishing Staff Disclosures
Mary Jo Krey, Eileen McCaffrey, and Sharon Hill-Ingram of Haymarket Medical Education have nothing to disclose with regard to commercial support.
AMA PRA Category 1 Credit(s)TM
Albert Einstein College of Medicine of Yeshiva is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Albert Einstein College of Medicine of Yeshiva designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Each course participant should only claim credits commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine of Yeshiva University, Meda Pharmaceuticals, Inc., and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine of Yeshiva University, Meda Pharmaceuticals, Inc., and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
If you have any questions relating to the accreditation of this activity, please contact Mildred Shields Adighiuzor, Associate Director, Albert Einstein College of Medicine, CME Marketing at (718) 920-6674.